Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Molecular Pharmacology|May 1, 1987
CGS 9343B, a novel, potent, and selective inhibitor of calmodulin activityJ A Norman, J Ansell, G A Stone, et al.Acta Crystallographica. Section D, Biological Crystallography|March 1, 1997
Characterization, crystallization and preliminary crystallographic analysis of human recombinant cyclooxygenase-2S Di Marco, J P Priestle, M G Grütter, et al.The Journal of Biological Chemistry|May 30, 1998
Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxinZ Chen, X Zhang, N C Gonnella, et al.The EMBO Journal|April 1, 1985
2-Nitroimipramine: a photoaffinity probe for the serotonin uptake/tricyclic binding site complexL P Wennogle, R A Ashton, D I Schuster, et al.Brain Research Bulletin|February 1, 1985
Heterogeneity of brain benzodiazepine receptors: effects of physiological conditionsA S Lippa, K M Garrett, B Tabakoff, et al.Journal of Cellular Biochemistry|July 1, 1994
Stabilization of C5a receptor--G-protein interactions through ligand bindingL P Wennogle, L Conder, C Winter, et al.Cell Biochemistry and Biophysics|December 11, 1999
Understanding the cellular uptake of phosphopeptidesA J Allentoff, S Mandiyan, H Liang, et al.Pharmacology, Biochemistry, and Behavior|July 1, 1982
Human brain receptor alterations in suicide victimsL R Meyerson, L P Wennogle, M S Abel, et al.Biochemistry|September 10, 1996
Characterization of SH2-ligand interactions via library affinity selection with mass spectrometric detectionM A Kelly, H Liang, I I Sytwu, et al.Peptides|January 1, 1988
Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidneyJ L Sonnenberg, Y Sakane, A Y Jeng, et al.Pageof 4